CompletedNot Applicable

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

United States14 participantsStarted 2017-12-06

Plain-language summary

This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept negative thoughts and feelings and how to live in the present without worrying about the future or past may improve coping skills in patients with stage III-IV cancer and their partners.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with stage 3 or 4 breast, cervical, colorectal, endometrial, hepatobiliary, lung, melanoma, gynecological, prostate cancer in the past six months * Married or cohabiting with a significant other of either gender for more than one year * At the time of recruitment, a life expectancy of greater than 6 months and/or a Karnofsky performance status of 80 or above or an Eastern Cooperative Oncology Group (ECOG) score of 0 or 1 * English speaking * No significant hearing impairment that would prevent participation in sessions * Live within a 1 hour commuting distance from Rutgers Cancer Institute of New Jersey Exclusion Criteria: * Partner cannot have cancer diagnosis (other than non-melanoma skin cancer) and be currently receiving treatment

What they're measuring

Change in acceptance as measured by the COPE acceptance subscale

Timeframe: Baseline to 1-week post intervention

Change in avoidance as measured by the Acceptance and Action Questionnaire-II

Timeframe: Baseline to 1-week post intervention

Change in value based living as measured by the Valued Living questionnaire

Timeframe: Baseline to 1-week post intervention

Feasibility defined as acceptance

Timeframe: Up to 1-week post intervention

Feasibility defined as session drop out

Timeframe: Up to 1-week post intervention

Feasibility defined as survey follow ups

Timeframe: Up to 1-week post intervention

Trial details

NCT IDNCT03112668

SponsorRutgers, The State University of New Jersey

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-01-25

View on ClinicalTrials.gov More Malignant Female Reproductive System Neoplasm trials

Plain-language summary

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change in acceptance as measured by the COPE acceptance subscale

Timeframe: Baseline to 1-week post intervention

Change in avoidance as measured by the Acceptance and Action Questionnaire-II

Timeframe: Baseline to 1-week post intervention

Change in value based living as measured by the Valued Living questionnaire

Timeframe: Baseline to 1-week post intervention

Feasibility defined as acceptance

Timeframe: Up to 1-week post intervention

Feasibility defined as session drop out

Timeframe: Up to 1-week post intervention

Feasibility defined as survey follow ups

Timeframe: Up to 1-week post intervention